Bekemeier H and Sänze JU |
Vasodepression ex vivo after administration of inflammatory mediators in vivo in the rat. |
1989 |
Agents Actions |
pmid:2476918
|
Kusner EJ et al. |
Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat. |
1987 |
Agents Actions |
pmid:3577957
|
Northover AM |
In vitro effects of PAF on venous endothelial cell actin disposition. |
1992 |
Agents Actions |
pmid:1509977
|
Anderson GP et al. |
Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. |
1988 |
Agents Actions |
pmid:3136622
|
Benveniste J |
Platelet-activating factor (PAF-acether): present status. |
1981 |
Agents Actions |
pmid:6176101
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding. |
1984 |
Agents Actions |
pmid:6532184
|
Adolfs MJ et al. |
PAF-acether modifies human peritoneal macrophage cAMP levels in a biphasic fashion. |
1989 |
Agents Actions |
pmid:2540635
|
Neumann M and Kownatzki E |
The effect of adherence on the generation of reactive oxygen species by human neutrophilic granulocytes. |
1989 |
Agents Actions |
pmid:2540640
|
de Bernardis E et al. |
Protective effects of papaverine salicylate in mouse ear dermatitis and PAF-induced rat paw oedema. |
1994 |
Agents Actions |
pmid:7847181
|
Jouquey S et al. |
Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. |
1988 |
Agents Actions |
pmid:2459935
|
Zijlstra FJ et al. |
The effects of PAF-acether and FMLP on eicosanoid production in guinea pig alveolar macrophages. |
1989 |
Agents Actions |
pmid:2711928
|
Nijkamp FP et al. |
Role of platelet activating factor in the endotoxin induced tracheal hyperreactivity to histamine in the guinea pig. |
1989 |
Agents Actions |
pmid:2711929
|
Oliver JL et al. |
Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF. |
1989 |
Agents Actions |
pmid:2711930
|
Taira M et al. |
Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. |
1988 |
Agents Actions |
pmid:3407549
|
McLeod J et al. |
Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on substance P-induced histamine release from rat peritoneal mast cells. |
1990 |
Agents Actions |
pmid:1695435
|
Izzo AA et al. |
Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents. |
1994 |
Agents Actions |
pmid:7524288
|
Jenei B et al. |
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function). |
1991 |
Agents Actions |
pmid:1862750
|
Lecrubier C et al. |
Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. |
1983 |
Agents Actions |
pmid:6858789
|
Kantar A et al. |
Effect of PAF on erythrocyte membrane heterogeneity: a fluorescence study. |
1991 |
Agents Actions |
pmid:1862752
|
Glaser KB et al. |
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). |
1993 |
Agents Actions |
pmid:8273577
|